Introduction:The UK Renal Registry (UKRR) collects, analyses and reports data from the UK’s 71 adult and 13 paediatric renal centres. Recently, the UKRR dataset was widened to include not only patients on renal replacement therapy (RRT) for end-stage kidney disease (ESKD) but also patients with acute kidney injury (AKI) in primary and secondary care (in England only) and patients with chronic kidney disease (CKD) in secondary care nephrology not on dialysis.The UKRR annual report comprises renal centre comparisons and analyses of attainment of the Renal Association audit measures published in their guidelines 1, national averages and long-term trends. Currently, only patients on RRT for ESKD are included.To improve the timeliness of data reporting, the format of the UKRR 21st Annual Report - data to December 31, 2017 2 differs significantly to that of previous years. In brief, there is now very little clinical commentary, there are fewer chapters and these reflect treatment types and stage, and there is greater alignment of analyses to the Renal Association guidelines 1 - consequently, for example, phosphate and parathyroid hormone are no longer included in the report.In this article, we summarise the analyses of adult patient data presented in the UKRR 21st Annual Report. The corresponding paediatric summary is published separately in this issue. The full report can be accessed at https://www.renalreg.org/reports/data_to_end_2017.
展开▼
